Literature DB >> 2249184

The Patterns of Care Outcome Study for cancer of the uterine cervix. Results of the Second National Practice Survey.

L Coia1, M Won, R Lanciano, V A Marcial, K Martz, G Hanks.   

Abstract

This report summarizes the outcome results of the Patterns of Care Study (PCS) of cancer of the uterine cervix from 565 patients treated in 1978. The 5-year survival with no evidence of disease was: Stage I, 74%; Stage II, 56%; and Stage III, 33%. The 5-year local in-field failure rate was: Stage I, 12%, Stage II, 27%; and Stage III, 51%. Extent of parametrial involvement, unilateral versus bilateral, may be important in determining survival and local failure. The four-year actuarial survival was 58% for unilateral involvement versus 47% for bilateral (P = 0.06), and the local failure rate was 32% for unilateral versus 45% for bilateral (P less than 0.05). When analyzed by stage, patients with Stage IIb disease with unilateral parametrial involvement showed a trend toward improved survival and decreased local failure compared with those with bilateral Stage IIb cancers (P = 0.1). The use of intracavitary irradiation significantly improved survival and reduced local failures. Furthermore, the number of intracavitary applications was important. When two or more intracavitary applications were used compared with one application, local in-field failure was significantly reduced, 29% versus 17% at 4 years (P less than 0.001), and four-year survival was improved, 60% versus 73% (P = 0.01). The four-year actuarial rate of major complications depended on the stage: Stage I, 8%; Stage II, 15%; and Stage III, 13%. There was a statistically significant increase in major complications in patients undergoing laparotomy for staging versus no laparotomy 23% versus 11% at 4 years (P less than or equal to 0.01) and a trend toward increased major complications in patients who were thin or had prior abdominal surgery. This study confirmed the stage-dependent outcome of treatment of cancer of the uterine cervix with radiation and indicated that further division of Stage IIb to indicate prognostic significance of unilateral or bilateral parametrial involvement may be warranted. This study also confirmed the importance of intracavitary radiation in optimizing control established by the 1973 PCS. It further suggests that where possible, two intracavitary insertions may yield better results than one insertion.

Entities:  

Mesh:

Year:  1990        PMID: 2249184     DOI: 10.1002/1097-0142(19901215)66:12<2451::aid-cncr2820661202>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  30 in total

1.  Radical radiotherapy for locally advanced cancer of uterine cervix.

Authors:  Jeung Eun Lee; Seung Jae Huh; Won Park; Do Hoon Lim; Yong Chan Ahn; Chang Soo Park; Byoung Gie Kim; Duk Soo Bae; Je Ho Lee; Chong Taik Park; Tae Jin Kim; Kyung Taek Lim; Hwan Wook Chung; Ki Heon Lee; Jae Uk Shim
Journal:  Cancer Res Treat       Date:  2004-08-31       Impact factor: 4.679

Review 2.  Recent developments and best practice in brachytherapy treatment planning.

Authors:  C D Lee
Journal:  Br J Radiol       Date:  2014-06-02       Impact factor: 3.039

Review 3.  Psychiatric Care of the Radiation Oncology Patient.

Authors:  Emily G Holmes; Jordan A Holmes; Eliza M Park
Journal:  Psychosomatics       Date:  2017-04-15       Impact factor: 2.386

4.  Impact of human papillomavirus genotype on response to treatment and survival in patients receiving radiotherapy for squamous cell carcinoma of the cervix.

Authors:  Jannatul Ferdousi; Yutaka Nagai; Tsuyoshi Asato; Makoto Hirakawa; Morihiko Inamine; Wataru Kudaka; Ken-Ichi Kariya; Yoichi Aoki
Journal:  Exp Ther Med       Date:  2010-05-01       Impact factor: 2.447

5.  A preliminary results of a randomized trial comparing monthly 5-flourouracil and cisplatin to weekly cisplatin alone combined with concurrent radiotherapy for locally advanced cervical cancer.

Authors:  Young Seok Kim; Seong Soo Shin; Eun Kyung Choi; Jong Hoon Kim; Seung Do Ahn; Sang-wook Lee; Heon-Jin Park; Young-Tak Kim; Jung-Eun Mok; Joo-Hyun Nam
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

6.  Correlation of point B and lymph node dose in 3D-planned high-dose-rate cervical cancer brachytherapy.

Authors:  Larissa J Lee; Cheryl A Sadow; Anthony Russell; Akila N Viswanathan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-13       Impact factor: 7.038

7.  The efficacy of concurrent cisplatin and 5-flurouracil chemotherapy and radiation therapy for locally advanced cancer of the uterine cervix.

Authors:  Il Jung Choi; Moon Seok Cha; Eunku Seul Park; Myung Seok Han; Youngmin Choi; Goo Hwa Je; Hyun Ho Kim
Journal:  J Gynecol Oncol       Date:  2008-06-20       Impact factor: 4.401

8.  A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer.

Authors:  Fady B Geara; Ali Shamseddine; Ali Khalil; Mirna Abboud; Maya Charafeddine; Muhieddine Seoud
Journal:  Radiat Oncol       Date:  2010-09-23       Impact factor: 3.481

9.  Should helical tomotherapy replace brachytherapy for cervical cancer? Case report.

Authors:  Chen-Hsi Hsieh; Ming-Chow Wei; Yao-Peng Hsu; Ngot-Swan Chong; Yu-Jen Chen; Sheng-Mou Hsiao; Yen-Ping Hsieh; Li-Ying Wang; Pei-Wei Shueng
Journal:  BMC Cancer       Date:  2010-11-23       Impact factor: 4.430

10.  Clinical results of external beam radiotherapy alone with a concomitant boost program or with conventional fractionation for cervical cancer patients who did not receive intracavitary brachytherapy.

Authors:  Kanji Matsuura; Tomoyuki Okabe; Kazushi Fujita; Hirotoshi Tanimoto; Yukio Akagi; Masayuki Kagemoto
Journal:  J Radiat Res       Date:  2012-08-01       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.